On Monday, Good Morning America anchor Robin Roberts announced to viewers that she has been diagnosed with myelodysplastic syndrome, a blood and bone marrow disease once known as preleukemia. Roberts, ...

Myelodysplastic syndromes (MDS) are treated based on type and risk assessment, but traditional therapies may not work for everyone. Clinical trials offer a way to explore emerging treatments and ...

If you have myelodysplastic syndromes (MDS) and are feeling healthy, your doctor will likely take a “watch and wait” approach. You may feel anxiety and fear toward this approach, but there are ways to ...

Using next-generation sequencing (NGS) methods to analyze cell-free DNA in the blood of patients with myelodysplastic syndrome (MDS) yields more accurate results than the current standard approach of ...

Rigel Pharmaceuticals recently announced the enrollment of the first patient in the dose expansion phase of its ongoing Phase 1b study of R289 in relapsed or refractory lower-risk myelodysplastic ...

More than half of patients with high-risk myelodysplastic syndrome may not be receiving guideline-recommended treatment with ...

DelveInsight's " Myelodysplastic Syndrome with Excess Blasts2 Market Insight, Epidemiology And Market Forecast - 2032 " report provides an in-depth understanding of the Myelodysplastic Syndrome with ...

It seemed unusual to have such graphic descriptions such as “I ate it up and spit it out” in the middle of a melodic song.

Doc made a shocking revelation about Felicity Huffman's character, Joan, dealing with a secret cancer battle. During the ...

The FDA approved ivosidenib for treatment of certain adults with relapsed or refractory myelodysplastic syndromes. The indication applies to use of the agent in adults who harbor susceptible ...

Keros Therapeutics will present Phase 2 data for the drug, elritercept, at the annual meeting of the American Society of Hematology. Meanwhile, the Takeda deal enables Keros to focus on two wholly ...

Myelodysplastic syndrome is an umbrella term used to describe disorders characterized by the bone marrow's inability to produce normal blood cells. Researchers from Charité - Universitätsmedizin ...